approval
saveEYLEA HD (AFLIBERCEPT) — FDA approval
community read0 votes
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
same company · ±60 days · 5
- approvaldupilumab: DUPIXENT (DUPILUMAB) — FDA approvalApr 16, 2026
- pdufadupilumab: Regeneron Pharmaceuticals Inc — dupilumab (PDUFA)Apr 27, 2026
- earningsREGENERON PHARMACEUTICALS, INC. earningsApr 29, 2026
- phase 2 completioncemiplimab: Regeneron Pharmaceuticals Inc — cemiplimab (Phase II Trial Completion)Apr 30, 2026
- approvaldupilumab: DUPIXENT (DUPILUMAB) — FDA approvalFeb 23, 2026
🐶 often sniffed alongside
top 8- tagApproval44 co-mentions · 15 sources
- drugEylea32 co-mentions · 15 sources
- drugYESAFILI18 co-mentions · 7 sources
- drugaflibercept biosimilar17 co-mentions · 10 sources
- drugOPUVIZ8 co-mentions · 4 sources
- drugENZEEVU6 co-mentions · 3 sources
- companySamsung Bioepis Co Ltd4 co-mentions · 4 sources
- companyBiocon Biologics Ltd4 co-mentions · 2 sources
comments(0)
5-min edit window · permanent after that